CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-02. AI was used for research and drafting; the existence of all 1 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 1986 · Search date 2026-08-02 · Methodology v1.0

Four gold kiwifruits daily equivalent,
does it really help with Shorter duration of cold symptoms?

30-Second Summary
C
Evidence Grade C · 46 · Safety caution
Overall infection incidence was unchanged, while only two symptoms improved in symptomatic subsets
Kiwifruit can cause food allergy and oral-allergy syndrome. People with latex or related fruit allergies should watch for reactions.
What the
research shows
The verdict is C with 46 points. Overall respiratory-infection incidence did not differ, while only some symptom durations were shorter among people who became ill. The sore-throat difference was conventionally large, whereas the head-congestion difference was small.
What the
ads claim
Nutrients and antioxidants in gold kiwifruit can be expanded into a claim that it prevents colds or shortens every symptom. The trial did not reduce overall incidence and found positive results only for selected symptoms.
*

Useful facts when choosing a product

  • The intervention combined two fresh gold kiwifruits with freeze-dried material equivalent to two more; it was not four fresh fruits.
  • Banana was an active food comparator, not no treatment.
  • Verdict 1167 is D with 31 points for sleep, while verdict 532 is C with 55 points for functional constipation; both address different outcomes.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.four-gold-kiwifruits-equivalent-two-fresh-and-two-freeze-dried.UNK.shorter-duration-of-cold-symptoms.assess.MULTI

Unknown > Four gold kiwifruits equivalent: two fresh and two freeze-dried > Unknown > Shorter duration of cold symptoms > Association or change assessment > Multiple: primary unresolved

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 1986 · C 46
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Hunter and colleagues conducted the randomized crossover study from July to November 2008. Two nonadherent participants and three noncompleters were excluded. ZESPRI International Limited funded the work, and bananas were the active food comparator.

02

Why this is classified as C (46)

This was one manufacturer-funded, small, short trial using completer data and bananas as the comparator. Overall incidence did not differ, selected symptom subsets were positive, and the converted magnitudes differed by endpoint, yielding C with 46 points.

Counterpoint. The two selected symptom durations were statistically shorter, so the study was not wholly null.

Rejudgment record. Cross-check applied — Cross-checked overall incidence, symptom-specific denominators, comparator, funding, and effect-size reconstructability against the article

Stored scoring profile
EndpointPSymptom or function itself is the target - including patient reports and performance tests
ReplicationR1Single confirmatory trial
IndependenceI0Evidence comes only from manufacturer studies
Effect sizeE~Statistically positive but below the threshold

Stored derived and displayed grades match; this is not a current recalculation or validity check (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Gold kiwifruit contains vitamins and carotenoidsCThis is a composition fact separate from cold efficacy.
Four gold-kiwifruit equivalents daily shorten cold symptomsCOverall incidence was null and only symptom subsets were positive.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Hunter DC et al., British Journal of Nutrition, 2012Randomized crossover trial, four weeks per food37 randomized, 32 analyzed; symptom subsets of 20 and 16ZESPRI International LimitedOverall respiratory-infection incidence and symptom durationNo overall incidence difference; sore throat 5.42 to 2.01 days and head congestion 4.69 to 0.88 daysDirect trial with positive subsets; the sore-throat difference was conventionally large and the congestion difference small
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-02).

Hunter DC, Skinner MA, Wolber FM, et al. Consumption of gold kiwifruit reduces severity and duration of selected upper respiratory tract infection symptoms and increases plasma vitamin C concentration in healthy older adults. Br J Nutr. 2012;108:1235-1245. DOI: 10.1017/S0007114511006659.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-02 · Corrections: none

Cite this verdict

Four gold kiwifruits daily equivalent x cold symptom duration Evidence Grade C card
[Chamgap] Four gold kiwifruits daily equivalent x cold symptom duration — Evidence Grade C·46. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/gold-kiwifruit-four-daily-cold-symptom-duration/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.